RSS Feed for Biotech, Pharmaceutical and Clinical Research News | BioSpace (Generated by New Sloth)
Updated: 8 hours 56 min ago
Sun, 09/03/2023 - 02:00
How ChatGPT Can–and Can't–Help Your Job Search 3/9/2023
Sun, 09/03/2023 - 02:00
QurAlis’ Biomarker-Driven Approach Attracts $88M in Series B 3/9/2023
Sun, 09/03/2023 - 02:00
Lilly’s Alzheimer’s Struggles Continue as Preclinical Disease Asset Fails Phase III 3/9/2023
Sun, 09/03/2023 - 02:00
Closing the Opportunity Gap: How Inceptor Bio Supports Women Leaders 3/9/2023
Sat, 08/05/2023 - 02:00
Boehringer Ingelheim to Mine Ginkgo’s Molecules in $406M Undruggable Targets ... 5/8/2023
Sat, 08/05/2023 - 02:00
BioNTech Looks to Expand into Other Markets as COVID-19 Revenues Dwindle 5/8/2023
Sat, 08/05/2023 - 02:00
BMS Cuts Jobs in New Jersey, Cites ‘Constantly Evolving’ Business Model 5/8/2023
Sat, 08/05/2023 - 02:00
Biopharma Bets Big on Antibody-Drug Conjugates 5/8/2023
Sat, 08/05/2023 - 02:00
Opinion: Hope on the Horizon for Sjogren’s Syndrome 5/8/2023
Sat, 08/05/2023 - 02:00
FDA Action Alert: Sarepta, Protalix, Otsuka/Lundbeck and More 5/8/2023
Sat, 08/05/2023 - 02:00
FDA Guidance May Bolster Confidence in Decentralized Clinical Trials 5/8/2023
Thu, 08/03/2023 - 02:00
In Tough Market, CODA Quietly Shuts Doors 3/8/2023
Thu, 08/03/2023 - 02:00
BioMarin Answers BridgeBio's Challenge with sNDA for Achondroplasia 3/8/2023
Thu, 08/03/2023 - 02:00
FDA Accepts Mesoblast’s Ryoncil Resubmission for Pediatric GVHD 3/8/2023
Thu, 08/03/2023 - 02:00
Co-working could Drive Innovation, Distribution of Talent Across U.S. 3/8/2023
Thu, 08/03/2023 - 02:00
The Decade of RNA Delivery – Beyond the Liver 3/8/2023
Tue, 07/04/2023 - 02:00
Makena Saga Concludes as FDA Withdraws Approval for Only Preterm Birth Drug on Market 4/7/2023
Tue, 07/04/2023 - 02:00
Novavax Presents COVID-19 Booster and Flu Combo Vaccine Studies 4/7/2023
Tue, 07/04/2023 - 02:00
World Vaccine Congress Panel Highlights Exigency of AMR Global Health Crisis 4/7/2023
Tue, 07/04/2023 - 02:00
Merck/Eisai Drops Melanoma Program for Keytruda-Lenvima Combo After Phase III Fail 4/7/2023